AAAAAA
Results:
1-14
|
Results: 14
Authors:
PIECORO LT
WERMELING DP
SCHMITT FA
ASHFORD JW
Citation: Lt. Piecoro et al., SEIZURES IN PATIENTS RECEIVING CONCOMITANT ANTIMUSCARINICS AND ACETYLCHOLINESTERASE INHIBITOR, Pharmacotherapy, 18(5), 1998, pp. 1129-1132
Authors:
PETTIGREW LC
BIEBER F
LETTIERI J
WERMELING DP
FREDERICK D
SCHMITT A
TIKHTMAN AJ
ASHFORD JW
SMITH CD
WEKSTEIN DR
MARKESBERY WR
ORAZEM J
RUZICKA BB
MAS J
GULANSKI B
Citation: Lc. Pettigrew et al., PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF METRIFONATE IN PATIENTS WITH ALZHEIMERS-DISEASE, Journal of clinical pharmacology, 38(3), 1998, pp. 236-245
Authors:
WERMELING DP
PIECORO LT
FOSTER TS
Citation: Dp. Wermeling et al., FINANCIAL IMPACT OF CLINICAL RESEARCH ON A HEALTH SYSTEM, American journal of health-system pharmacy, 54(15), 1997, pp. 1742-1751
FRONTAL-LOBE PHOSPHORUS-METABOLISM AND NEUROPSYCHOLOGICAL FUNCTION INAGING AND IN ALZHEIMERS-DISEASE
Authors:
SMITH CD
PETTIGREW LC
AVISON MJ
KIRSCH JE
TINKHTMAN AJ
SCHMITT FA
WERMELING DP
WEKSTEIN DR
MARKESBERRY WR
Citation: Cd. Smith et al., FRONTAL-LOBE PHOSPHORUS-METABOLISM AND NEUROPSYCHOLOGICAL FUNCTION INAGING AND IN ALZHEIMERS-DISEASE, Annals of neurology, 38(2), 1995, pp. 194-201
Authors:
WERMELING DP
CHANDLER MHH
SIDES GD
COLLINS D
MUSE KN
Citation: Dp. Wermeling et al., DIRITHROMYCIN INCREASES ETHINYL ESTRADIOL CLEARANCE WITHOUT ALLOWING OVULATION, Obstetrics and gynecology, 86(1), 1995, pp. 78-84
Authors:
SOBEL JD
BROOKER D
STEIN GE
THOMASON JL
WERMELING DP
BRADLEY B
WEINSTEIN L
Citation: Jd. Sobel et al., SINGLE ORAL DOSE FLUCONAZOLE COMPARED WITH CONVENTIONAL CLOTRIMAZOLE TOPICAL THERAPY OF CANDIDA-VAGINITIS, American journal of obstetrics and gynecology, 172(4), 1995, pp. 1263-1268
Authors:
WERMELING DP
FEILD CJ
SMITH DA
CHANDLER MHH
CLIFTON GD
BOYLE DA
Citation: Dp. Wermeling et al., EFFECTS OF LONG-TERM ORAL CARVEDILOL ON THE STEADY-STATE PHARMACOKINETICS OF ORAL DIGOXIN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Pharmacotherapy, 14(5), 1994, pp. 600-606
Authors:
SHEDLOFSKY SI
BLOUIN RA
MCCLAIN CJ
JOHNSON SB
WERMELING DP
Citation: Si. Shedlofsky et al., ANALYSIS OF MEDICATIONS ADMINISTERED TO PATIENTS WITH SEPSIS SYNDROME- LIKELIHOOD OF ADVERSE DRUG-INTERACTIONS, Hepatology, 20(4), 1994, pp. 10000398-10000398
Authors:
APPLEFELD JJ
KASMER RJ
HAK LJ
DUKES GE
WERMELING DP
MCCLAIN CJ
Citation: Jj. Applefeld et al., A DOSE-RESPONSE STUDY OF ORALLY-ADMINISTERED TORSEMIDE IN PATIENTS WITH ASCITES DUE TO CIRRHOSIS, Alimentary pharmacology & therapeutics, 8(4), 1994, pp. 397-402
Authors:
MCCOY RA
CLIFTON GD
CLEMENTI WA
SMITH MD
GARVEY TQ
WERMELING DP
SCHWARTZ SE
Citation: Ra. Mccoy et al., PHARMACODYNAMICS OF RACEMIC AND S(-)-ATENOLOL IN HUMANS, Journal of clinical pharmacology, 34(8), 1994, pp. 816-822
Authors:
CLIFTON GD
HARRISON MR
WERMELING DP
LONG RA
FLECK RJ
ROLLERI RL
WELLER S
BROWN AR
WELCH RM
Citation: Gd. Clifton et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW CARDIOTONIC VASODILATOR AGENT, 349U85, IN NORMAL SUBJECTS, Clinical pharmacology and therapeutics, 55(1), 1994, pp. 55-63
Authors:
WERMELING DP
SELWITZ AS
Citation: Dp. Wermeling et As. Selwitz, CURRENT ISSUES SURROUNDING WOMEN AND MINORITIES IN DRUG TRIALS, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 904-911
Authors:
SAGRAVES R
RAEBEL MA
JERMAIN DM
OCONNELL MB
WERMELING DP
Citation: R. Sagraves et al., WOMEN AS RESEARCH SUBJECTS, Pharmacotherapy, 13(5), 1993, pp. 534-542
Authors:
WERMELING DP
Citation: Dp. Wermeling, VALUE OF INVESTIGATIONAL DRUGS, American journal of hospital pharmacy, 50(8), 1993, pp. 1576-1576
Risultati:
1-14
|